Ketalar

Ketamine, the active ingredient in Ketalar, is a NMDA receptor antagonist presented as an injectable solution for intramuscular and intravenous use. It provides rapid dissociative anesthesia and analgesia for surgical procedures and certain emergency indications. It is used in adult patients undergoing operative interventions and in selected pediatric cases under specialist supervision.

GNH USA supplies Ketalar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and offers reliable global logistics for this essential anesthetic agent.

Ketalar (ketamine) acts on the NMDA receptor pathway to produce dissociative anesthesia and analgesia.

- Induction of anesthesia: provides rapid onset of dissociative anesthesia for surgical procedures. - Analgesia: delivers potent pain relief during and after operative interventions. - Sedation: enables controlled sedation for diagnostic or therapeutic procedures requiring patient immobility. - Refractory status epilepticus: serves as an adjunctive agent when conventional anticonvulsants fail. - Treatment‑resistant depression (off‑label): may be administered under specialist supervision to alleviate depressive symptoms.

Ketalar may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Elevated blood pressure - Increased heart rate - Nausea or vomiting - Visual disturbances

Serious or Rare Side Effects: - Airway obstruction - Severe respiratory depression - Emergence delirium or psychotomimetic reactions

When using Ketalar, clinicians should observe specific safety measures to minimize risks.

- Cardiovascular monitoring: observe blood pressure and heart rate continuously during administration. - Respiratory support: be prepared to manage airway and provide ventilation if respiratory depression occurs. - Psychiatric assessment: evaluate for pre‑existing psychosis, as ketamine can exacerbate mental disturbances. - Drug interactions: avoid concurrent use with other central nervous system depressants without careful titration. - Pregnancy and lactation: use only if benefits outweigh potential risks; data are limited. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ketalar interacts with several agents that can alter its safety or efficacy.

Major Interactions (Avoid): - Opioids and benzodiazepines: combined CNS depression may cause profound respiratory depression. - Sympathomimetic drugs: may exacerbate hypertension and tachycardia. - MAO inhibitors: increase risk of hypertensive crisis.

Moderate Interactions (Monitor Closely): - Antidepressants (e.g., SSRIs): may heighten psychotomimetic effects. - Anticholinergic agents: can intensify dry mouth and urinary retention. - Inhalational anesthetics: may require dose adjustments to avoid additive cardiovascular effects.